“…[7,8] To avoid this phenomenon in the chemical therapy process, much attention has been focused on polymer-drug conjugates to enhance the poor bioavailability of these chemical drugs. Moreover, the linkage between the polymer and the chemical drug is designed so that it is degradable and responsivet oi ntracellular changes so as to release the drug efficiently.G enerally,s everal stimuli-responsive bonds, [11][12][13][14][15][16] such as imine, hydrazone, disulfide bond, acid-labile acetal, ketal, and carbamate linkages, can be cleavedf rom the polymer under the low pH value conditions of endosomes/lysosomes or the high cellular glutathione (GSH) levels in tumor tissue, thus providing better security in the treatment process. Moreover, the linkage between the polymer and the chemical drug is designed so that it is degradable and responsivet oi ntracellular changes so as to release the drug efficiently.G enerally,s everal stimuli-responsive bonds, [11][12][13][14][15][16] such as imine, hydrazone, disulfide bond, acid-labile acetal, ketal, and carbamate linkages, can be cleavedf rom the polymer under the low pH value conditions of endosomes/lysosomes or the high cellular glutathione (GSH) levels in tumor tissue, thus providing better security in the treatment process.…”